Name | Number of supported studies | Average coverage | |
---|---|---|---|
placental villous trophoblast | 3 studies | 74% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
placenta | 3 studies | 29% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 486.43 | 180 / 180 | 98% | 4.42 | 423 / 430 |
prostate | 100% | 244.06 | 245 / 245 | 95% | 2.80 | 479 / 502 |
thymus | 100% | 257.89 | 653 / 653 | 91% | 2.86 | 548 / 605 |
uterus | 100% | 318.98 | 170 / 170 | 83% | 3.83 | 380 / 459 |
esophagus | 100% | 223.92 | 1444 / 1445 | 75% | 3.63 | 137 / 183 |
bladder | 100% | 195.71 | 21 / 21 | 68% | 6.18 | 344 / 504 |
lung | 100% | 188.42 | 576 / 578 | 62% | 2.51 | 719 / 1155 |
brain | 100% | 264.85 | 2640 / 2642 | 60% | 1.06 | 423 / 705 |
breast | 100% | 251.95 | 459 / 459 | 59% | 3.07 | 660 / 1118 |
skin | 100% | 244.49 | 1808 / 1809 | 56% | 3.99 | 266 / 472 |
pancreas | 99% | 118.40 | 326 / 328 | 52% | 4.15 | 92 / 178 |
stomach | 100% | 163.10 | 359 / 359 | 28% | 0.75 | 81 / 286 |
intestine | 100% | 236.71 | 966 / 966 | 25% | 0.62 | 130 / 527 |
liver | 96% | 84.66 | 216 / 226 | 28% | 0.81 | 115 / 406 |
adrenal gland | 99% | 122.47 | 256 / 258 | 24% | 2.09 | 56 / 230 |
kidney | 100% | 152.64 | 89 / 89 | 12% | 0.20 | 111 / 901 |
spleen | 100% | 206.32 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.68 | 1 / 1 |
adipose | 100% | 202.11 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 211.33 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 109.88 | 834 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 103.70 | 770 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 3.15 | 41 / 45 |
peripheral blood | 79% | 93.99 | 731 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 40% | 1.85 | 32 / 80 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.28 | 6 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007040 | Biological process | lysosome organization |
GO_0006703 | Biological process | estrogen biosynthetic process |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0061370 | Biological process | testosterone biosynthetic process |
GO_0006694 | Biological process | steroid biosynthetic process |
GO_0071248 | Biological process | cellular response to metal ion |
GO_0060612 | Biological process | adipose tissue development |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0010467 | Biological process | gene expression |
GO_0060348 | Biological process | bone development |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0003824 | Molecular function | catalytic activity |
GO_0047035 | Molecular function | testosterone dehydrogenase (NAD+) activity |
GO_0072582 | Molecular function | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity |
GO_0036094 | Molecular function | small molecule binding |
GO_0047045 | Molecular function | testosterone 17-beta-dehydrogenase (NADP+) activity |
GO_0004303 | Molecular function | estradiol 17-beta-dehydrogenase [NAD(P)+] activity |
GO_0050661 | Molecular function | NADP binding |
GO_0030283 | Molecular function | testosterone dehydrogenase [NAD(P)+] activity |
GO_0005496 | Molecular function | steroid binding |
GO_0035410 | Molecular function | dihydrotestosterone 17-beta-dehydrogenase activity |
GO_0005515 | Molecular function | protein binding |
GO_0070401 | Molecular function | NADP+ binding |
GO_1903924 | Molecular function | estradiol binding |
Gene name | HSD17B1 |
Protein name | Estradiol 17-beta-dehydrogenase (EC 1.1.1.62) Hydroxysteroid 17-beta dehydrogenase 1 (cDNA FLJ50217, highly similar to Estradiol 17-beta-dehydrogenase 1) 17-beta-hydroxysteroid dehydrogenase type 1 (17-beta-HSD 1) (EC 1.1.1.51) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 1) (EC 1.1.1.62) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) |
Synonyms | SDR28C1 EDHB17 EDH17B1 E17KSR EDH17B2 |
Description | FUNCTION: Favors the reduction of estrogens and androgens. Converts estrone (E1) to a more potent estrogen, 17beta-estradiol (E2) . Also has 20-alpha-HSD activity. Uses preferentially NADH. . FUNCTION: Favors the reduction of estrogens and androgens. Uses preferentially NADH. . |
Accessions | ENST00000590299.5 ENST00000225929.5 ENST00000585807.6 A0A0A0MQS7 P14061 B4DU11 |